Thu. 8 Feb 2024, 6:02am ET
Benzinga
Earnings, News
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.94 by 10.64 percent. This is a 22.35 percent increase over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $336.25 million which beat the analyst consensus estimate of $320.29 million by 4.98 percent. This is a 10.14 percent increase over sales of $305.30 million the same period last year.